233 related articles for article (PubMed ID: 26160897)
1. Ly6Chigh Monocytes Protect against Kidney Damage during Sepsis via a CX3CR1-Dependent Adhesion Mechanism.
Chousterman BG; Boissonnas A; Poupel L; Baudesson de Chanville C; Adam J; Tabibzadeh N; Licata F; Lukaszewicz AC; Lombès A; Deterre P; Payen D; Combadière C
J Am Soc Nephrol; 2016 Mar; 27(3):792-803. PubMed ID: 26160897
[TBL] [Abstract][Full Text] [Related]
2. CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice.
Jacquelin S; Licata F; Dorgham K; Hermand P; Poupel L; Guyon E; Deterre P; Hume DA; Combadière C; Boissonnas A
Blood; 2013 Aug; 122(5):674-83. PubMed ID: 23775714
[TBL] [Abstract][Full Text] [Related]
3. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury.
Li L; Huang L; Sung SS; Vergis AL; Rosin DL; Rose CE; Lobo PI; Okusa MD
Kidney Int; 2008 Dec; 74(12):1526-37. PubMed ID: 18843253
[TBL] [Abstract][Full Text] [Related]
4. CX3CL1-CX3CR1 Interaction Increases the Population of Ly6C(-)CX3CR1(hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis.
Peng X; Zhang J; Xiao Z; Dong Y; Du J
J Immunol; 2015 Sep; 195(6):2797-805. PubMed ID: 26254342
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice.
Oh DJ; Dursun B; He Z; Lu L; Hoke TS; Ljubanovic D; Faubel S; Edelstein CL
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F264-71. PubMed ID: 18003857
[TBL] [Abstract][Full Text] [Related]
6. Spatio-temporal profile, phenotypic diversity, and fate of recruited monocytes into the post-ischemic brain.
Garcia-Bonilla L; Faraco G; Moore J; Murphy M; Racchumi G; Srinivasan J; Brea D; Iadecola C; Anrather J
J Neuroinflammation; 2016 Nov; 13(1):285. PubMed ID: 27814740
[TBL] [Abstract][Full Text] [Related]
7. CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis.
Sutti S; Locatelli I; Bruzzì S; Jindal A; Vacchiano M; Bozzola C; Albano E
Clin Sci (Lond); 2015 Nov; 129(9):797-808. PubMed ID: 26253086
[TBL] [Abstract][Full Text] [Related]
8. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.
Tacke F; Alvarez D; Kaplan TJ; Jakubzick C; Spanbroek R; Llodra J; Garin A; Liu J; Mack M; van Rooijen N; Lira SA; Habenicht AJ; Randolph GJ
J Clin Invest; 2007 Jan; 117(1):185-94. PubMed ID: 17200718
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
[TBL] [Abstract][Full Text] [Related]
10. NF-κB-mediated inverse regulation of fractalkine and CX3CR1 during CLP-induced sepsis.
Raspé C; Höcherl K; Rath S; Sauvant C; Bucher M
Cytokine; 2013 Jan; 61(1):97-103. PubMed ID: 23026294
[TBL] [Abstract][Full Text] [Related]
11. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival.
Lionakis MS; Swamydas M; Fischer BG; Plantinga TS; Johnson MD; Jaeger M; Green NM; Masedunskas A; Weigert R; Mikelis C; Wan W; Lee CC; Lim JK; Rivollier A; Yang JC; Laird GM; Wheeler RT; Alexander BD; Perfect JR; Gao JL; Kullberg BJ; Netea MG; Murphy PM
J Clin Invest; 2013 Dec; 123(12):5035-51. PubMed ID: 24177428
[TBL] [Abstract][Full Text] [Related]
12. Visualization of bone marrow monocyte mobilization using Cx3cr1gfp/+Flt3L-/- reporter mouse by multiphoton intravital microscopy.
Evrard M; Chong SZ; Devi S; Chew WK; Lee B; Poidinger M; Ginhoux F; Tan SM; Ng LG
J Leukoc Biol; 2015 Mar; 97(3):611-9. PubMed ID: 25516753
[TBL] [Abstract][Full Text] [Related]
13. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.
Yang XP; Mattagajasingh S; Su S; Chen G; Cai Z; Fox-Talbot K; Irani K; Becker LC
Circ Res; 2007 Nov; 101(10):1001-8. PubMed ID: 17885215
[TBL] [Abstract][Full Text] [Related]
14. Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.
Jung K; Heishi T; Khan OF; Kowalski PS; Incio J; Rahbari NN; Chung E; Clark JW; Willett CG; Luster AD; Yun SH; Langer R; Anderson DG; Padera TP; Jain RK; Fukumura D
J Clin Invest; 2017 Aug; 127(8):3039-3051. PubMed ID: 28691930
[TBL] [Abstract][Full Text] [Related]
15. CX3CR1-dependent endothelial margination modulates Ly6C
Hamon P; Loyher PL; Baudesson de Chanville C; Licata F; Combadière C; Boissonnas A
Blood; 2017 Mar; 129(10):1296-1307. PubMed ID: 28011675
[TBL] [Abstract][Full Text] [Related]
16. Mobilisation of the splenic monocyte reservoir and peripheral CX₃CR1 deficiency adversely affects recovery from spinal cord injury.
Blomster LV; Brennan FH; Lao HW; Harle DW; Harvey AR; Ruitenberg MJ
Exp Neurol; 2013 Sep; 247():226-40. PubMed ID: 23664962
[TBL] [Abstract][Full Text] [Related]
17. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
[TBL] [Abstract][Full Text] [Related]
18. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
19. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites.
Tsou CL; Peters W; Si Y; Slaymaker S; Aslanian AM; Weisberg SP; Mack M; Charo IF
J Clin Invest; 2007 Apr; 117(4):902-9. PubMed ID: 17364026
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor CX3CR1 promotes dendritic cell development under steady-state conditions.
Łyszkiewicz M; Witzlau K; Pommerencke J; Krueger A
Eur J Immunol; 2011 May; 41(5):1256-65. PubMed ID: 21425158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
